Skip to content
MarketScale
‹ Back to IndustriesHealthcare

Owning the Future of Healthcare: A Strong Data Foundation Powers Product Development

“We’re a patient-centric company that wants to empower organizations to cultivate data for the best outcomes.” Healthcare data is a valuable asset, but its collection, aggregation, and analysis are neither easy or simple. However, it’s the foundation for products that companies like Health Catalyst develop. Discussing the product and data perspective, the company’s first…

This story was produced through MarketScale. See how Healthcare teams put it to work with Executive Thought Leadership.

Share
“We’re a patient-centric company that wants to empower organizations to cultivate data for the best outcomes.”

Healthcare data is a valuable asset, but its collection, aggregation, and analysis are neither easy or simple. However, it’s the foundation for products that companies like Health Catalyst develop. Discussing the product and data perspective, the company’s first Chief Product Officer, Anne Marie Bickford, spoke with Owning the Future of Healthcare host Courtney Anne Echerd.

Bickmore began by talking about her journey. “I didn’t think graduating from nursing school, I’d have this position, but I’m glad to be blazing this trail.”

Bickmore’s background as a nurse prepared her very well for her current role. “A clinical background and one as an ED nurse helps me to pivot and look at what’s needed right now. It’s a way to triage.”

In discussing how she looks at data, Bickmore noted that the company’s products must be grounded in high-quality data. “The products sit on top of that, so the data analytics must be strong.”

Bickmore spoke about the challenges the healthcare industry faces. “We’ve been slower than others on standardizing, using, and getting the most value out of it. We have to combine sources then care and feed these data assets.”

Healthcare is now reaching a point where there’s better coordination of all these sources from claims, billing, and clinical. By doing this, many wonder if it’s good for the patient. Bickmore answered, “Yes, it is. We’re a patient-centric company that wants to empower organizations to cultivate data for the best outcomes. While these are operational applications, it’s still patient-centric because it keeps doors open, and patients have access to healthcare.”

What Bickmore noted is that the drive for better data shouldn’t be on the providers. “We need to use modern tools to make data more consumable. The tools need to change because it’s burning providers out.”

Healthcare: are you visible to AI?

Before they reach out, Healthcare buyers ask AI engines which vendors to trust. See how AI describes your company today, and where competitors show up instead.

Free workspace

You just read one expert. Imagine publishing your whole team.

This article was produced through MarketScale. Create a free workspace and turn your own team's expertise into articles, video, and social posts. No credit card, no demo required.

NPS +73 · 1,000+ creators · 38+ countries

What you get, free

Your own MarketScale Studio workspace
One video edit a month, on us
AI writing, editing, and publishing tools
In-platform coaching to learn the system

More Healthcare Insights

FDA clears UpDoc's LLM diabetes app, grants Aidoc breakthrough status as clinical AI crosses new regulatory thresholds

FDA clears UpDoc's LLM diabetes app, grants Aidoc breakthrough status as clinical AI crosses new regulatory thresholds

UpDoc has received FDA clearance for its LLM-driven diabetes management app, while Aidoc has been granted breakthrough device status for its AI-drafted radiology reports. This marks a significant milestone as clinical AI applications continue to gain regulatory approval and recognition. The advancements showcase the potential of AI in improving healthcare management and diagnostic processes.

  • 01UpDoc's diabetes management app receives FDA clearance.
  • 02Aidoc achieves breakthrough device status for AI radiology reports.
  • 03Regulatory milestones highlight AI's growing role in healthcare.

Jul 13, 2026

Cedars-Sinai's CDAIO on healthcare AI's second wave: workforce transformation, not just productivity

Cedars-Sinai's CDAIO on healthcare AI's second wave: workforce transformation, not just productivity

The chief data and AI officer at Cedars-Sinai discusses the evolving role of AI in healthcare. While the first wave of AI focused on enhancing productivity, the second wave is expected to transform job roles and the workforce structure. This shift indicates a deeper integration of AI technology in healthcare operations.

  • 01First wave of AI increased productivity in healthcare.
  • 02Second wave aims to restructure job roles.
  • 03AI will deeply integrate into healthcare operations.

Jul 13, 2026

Automation adoption gap widens in US manufacturing as medtech presses ahead

Automation adoption gap widens in US manufacturing as medtech presses ahead

Automation in US manufacturing lags, with 80% of factories lacking automation tools. In contrast, medtech manufacturers are advancing with technologies like micro-molding and ultrasonic welding. This disparity highlights a growing gap in technology adoption across different sectors.

  • 0180% of US factories have no automation.
  • 02Medtech manufacturers are investing in automation technologies.
  • 03There's an increasing divide in technology adoption across industries.

Jul 12, 2026

Explore More Healthcare Insights

Read more expert perspectives from across Healthcare.

Browse Healthcare Hub

For B2B teams

Your experts could be publishing here

Stories like this one run on content MarketScale captures from real practitioners. See how your team's expertise becomes coverage in Healthcare and beyond.

Book a 15-minute demo

Or call us. No forms required. We pick up. 214-945-2512